Use of E-cigarettes and Other Tobacco Products and Progression to Daily Cigarette Smoking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Pierce (2021)
Body esteem, weight-control outcome expectancies, and e-cigarette use among young adults.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Pokhrel (2021)
Nicotine delivery and cigarette equivalents from vaping a JUULpod.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Prochaska (2022)
Effect of Puffing Behavior on Particle Size Distributions and Respiratory Depositions From Pod-Style Electronic Cigarette, or Vaping, Products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ranpara (2021)
Free Radical, Carbonyl, and Nicotine Levels Produced by Juul Electronic Cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Reilly (2019)
Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on! nicotine pouches compared to combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Rensch (2021)
Investigating the DNa methylation profile of e-cigarette use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Richmond (2021)
Nicotine Exposure by Device Type among adult Electronic Nicotine Delivery System Users in the Population assessment of Tobacco and health Study, 2015-2016.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Rostron (2020)
Neural-hematopoietic-inflammatory axis in nonsmokers, electronic cigarette users, and tobacco smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ruedisueli (2022)
Pharmacokinetic and pharmacodynamic properties of aerosolized (“vaped”) ThC in adolescent male and female rats.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ruiz (2021)